NADPH oxidase-4 promotes eccentric cardiac hypertrophy in response to volume overload
Author(s) -
Moritz Schnelle,
Iain A. Sawyer,
Narayana Anilkumar,
Belal A. Mohamed,
Daniel A. Richards,
Karl Toischer,
Min Zhang,
Norman Catibog,
Greta J. Sawyer,
Héloïse MongueDin,
Katrin Schröder,
Gerd Hasenfuß,
Ajay M. Shah
Publication year - 2019
Publication title -
cardiovascular research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.774
H-Index - 219
eISSN - 1755-3245
pISSN - 0008-6363
DOI - 10.1093/cvr/cvz331
Subject(s) - nox4 , pressure overload , medicine , endocrinology , volume overload , nadph oxidase , ventricular remodeling , muscle hypertrophy , protein kinase b , eccentric , fibrosis , stroke volume , heart failure , ejection fraction , cardiology , biology , phosphorylation , chemistry , microbiology and biotechnology , oxidative stress , cardiac hypertrophy , physics , quantum mechanics
Chronic pressure or volume overload induce concentric vs. eccentric left ventricular (LV) remodelling, respectively. Previous studies suggest that distinct signalling pathways are involved in these responses. NADPH oxidase-4 (Nox4) is a reactive oxygen species-generating enzyme that can limit detrimental cardiac remodelling in response to pressure overload. This study aimed to assess its role in volume overload-induced remodelling.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom